Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle?

被引:22
作者
Bonkat, Gernot [1 ]
Rieken, Malte [1 ]
Mueller, Georg [1 ]
Roosen, Alexander [2 ]
Siegel, Fabian P. [3 ]
Frei, Reno [4 ]
Wyler, Stephen [1 ]
Gasser, Thomas [1 ]
Bachmann, Alexander [1 ]
Widmer, Andreas F. [5 ]
机构
[1] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland
[2] Univ Munich, Dept Urol, D-81377 Munich, Germany
[3] Heidelberg Univ, Univ Hosp Mannheim, Dept Urol, D-68167 Mannheim, Germany
[4] Univ Basel Hosp, Clin Microbiol Lab, CH-4031 Basel, Switzerland
[5] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland
关键词
Biofilm; Neurogenic inflammation; Microbial colonization; Pyuria; Storage lower; Urinary tract symptoms; Urine culture; Ureteral stent; INFECTION; IMPACT; DIAGNOSIS; DISEASES; SOCIETY;
D O I
10.1007/s00345-012-0849-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Ureteral stents are frequently associated with side effects. Most patients suffer from storage lower urinary tract symptoms (LUTS). Storage LUTS are commonly attributed to the irritation of the trigone, smooth muscle spasm or a combination of factors. The relationship between microbial ureteral stent colonization (MUSC) and de novo or worsening storage LUTS has not been investigated yet. Five hundred ninety-one polyurethane ureteral stents from 275 male and 153 female patients were prospectively evaluated. The removed stents were sonicated to dislodge adherent microorganisms. Urine flow cytometry was performed to detect pyuria. A standardized urinary symptom questionnaire was given to all patients. Thirty-five per cent of male and 28% of female cases showed de novo or worsened storage LUTS. MUSC was more common in patients with storage LUTS compared to patients without storage LUTS (men: 26 vs. 13%, respectively, P < 0.05; women: 63 vs. 48%, respectively, P = 0.13). Pyuria was significantly more common in patients with storage LUTS compared to patients without storage LUTS (men: 55 vs. 40%, respectively, P < 0.05; women: 70 vs. 45%, respectively, P < 0.05). No significant correlation was observed between the detected genera of microorganisms and storage LUTS. Our data show a significant association between MUSC- and stent-related de novo experienced or worsened storage LUTS in men. The incidence of MUSC is most common in both female and male patients with storage LUTS and accompanying pyuria. In these patients, a combination of antibiotics and anti-inflammatory drugs may be regarded as treatment option.
引用
收藏
页码:541 / 546
页数:6
相关论文
共 30 条
  • [1] The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society (Reprinted from Neurourology and Urodynamics, vol 21, pg 167-178, 2002)
    Abrams, P
    Cardozo, L
    Fall, M
    Griffiths, D
    Rosier, P
    Ulmsten, U
    Van Kerrebroeck, P
    Victor, A
    Wein, A
    [J]. UROLOGY, 2003, 61 (01) : 37 - 49
  • [2] Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin
    Apostolidis, A
    Brady, CM
    Yiangou, Y
    Davis, J
    Fowler, CJ
    Anand, P
    [J]. UROLOGY, 2005, 65 (02) : 400 - 405
  • [3] Improved detection of microbial ureteral stent colonisation by sonication
    Bonkat, Gernot
    Rieken, Malte
    Rentsch, Cyrill A.
    Wyler, Stephen
    Feike, Antje
    Schaefer, Juliane
    Gasser, Thomas
    Trampuz, Andrej
    Bachmann, Alexander
    Widmer, Andreas F.
    [J]. WORLD JOURNAL OF UROLOGY, 2011, 29 (01) : 133 - 138
  • [4] Ureteral stents: Impact of diameter and composition on patient symptoms
    Candela, JV
    Bellman, GC
    [J]. JOURNAL OF ENDOUROLOGY, 1997, 11 (01) : 45 - 47
  • [5] The use of stents in contemporary urology
    Chew, BH
    Knudsen, BE
    Denstedt, JD
    [J]. CURRENT OPINION IN UROLOGY, 2004, 14 (02) : 111 - 115
  • [6] The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection
    Chromek, Milan
    Slamova, Zuzana
    Bergman, Peter
    Kovacs, Laszlo
    Podracka, L'udmila
    Ehren, Ingrid
    Hokfelt, Tomas
    Gudmundsson, Gudmundur H.
    Gallo, Richard L.
    Agerberth, Birgitta
    Brauner, Annelie
    [J]. NATURE MEDICINE, 2006, 12 (06) : 636 - 641
  • [7] Does the size of ureteral stent impact urinary symptoms and quality of life?: A prospective randomized study
    Damiano, R
    Autorino, R
    De Sio, M
    Cantiello, F
    Quarto, G
    Perdonà, S
    Sacco, R
    D'Armiento, M
    [J]. EUROPEAN UROLOGY, 2005, 48 (04) : 673 - 678
  • [8] de Groat William C, 2009, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-540-79090-7_4
  • [9] Relief of Stent Related Symptoms: Review of Engineering and Pharmacological Solutions
    Dellis, Athanasios
    Joshi, Hrishi B.
    Timoney, Anthony G.
    Keeley, Francis X., Jr.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (04) : 1267 - 1272
  • [10] Biomaterials used in urology: Current issues of biocompatibility, infection, and encrustation
    Denstedt, JD
    Wollin, TA
    Reid, G
    [J]. JOURNAL OF ENDOUROLOGY, 1998, 12 (06) : 493 - 500